This research was designed to investigate how life science organizations interact with thought leaders throughout the phases of product development. This executive summary is meant to reveal how pharmaceutical organizations engage with thought leaders, which types of thought leaders are targeted during the various phases of a product development, which levels of influence are most pursued and what sort of activities are conducted during these exchanges.
Results are presented from a global perspective and for the regional segment of United States.
The global findings presented in this executive summary result from the input of 47 respondents from 34 life sciences organizations from 15 countries across Asia, Europe, Latin and North America. Findings for the US segment result from the input of 22 US-based respondents from 16 life sciences organizations.
Number of slides: 79
Format: Executive Summary Slide Deck, PDF
Price: $695 / $1,390 / $2,085